Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2001-3-20
pubmed:abstractText
We aimed to determine the rate of Helicobacter pylori (HP) recurrence and duodenal ulcer relapse in patients of a hospital in Singapore over a period of at least one year from the time of eradication. Ninety-six consecutive duodenal ulcer patients with biopsy-proven HP eradication and healed ulcer were seen at 3-month intervals, and follow-up endoscopy was performed when dyspepsia recurred, at the end of one year after eradication, or at the time of recall if the patient had been lost to follow-up. HP status was determined by antral and corpus biopsies and by antral cultures. Sixty-five had been given triple therapy, and 31 received dual therapy with omeprazole + amoxycillin or clarythromycin. Median time to follow-up endoscopy was 12 months. Six patients (6.25%) were positive for HP infection after eradication. Recurrence of HP infection was detected at 9 and 10 months after confirmation of HP eradication in two patients, and at between 13 and 20 months in the remaining four. Two of these had recurrent duodenal ulcer; all but one had erosive duodenitis. Two other patients had recurrent duodenal ulcer despite absence of HP reinfection; they admitted to taking low-dose aspirin. It was concluded that the recurrence of HP infection is low at the end of one year after successful eradication therapy in this urban East Asian population. Ulcer relapse occurred in 4.17% (4/96) of patients, and was associated with recurrent HP infection or NSAID exposure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0037-5675
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
382-6
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11256345-Adolescent, pubmed-meshheading:11256345-Adult, pubmed-meshheading:11256345-Age Distribution, pubmed-meshheading:11256345-Aged, pubmed-meshheading:11256345-Amoxicillin, pubmed-meshheading:11256345-Anti-Bacterial Agents, pubmed-meshheading:11256345-Anti-Ulcer Agents, pubmed-meshheading:11256345-Child, pubmed-meshheading:11256345-Clarithromycin, pubmed-meshheading:11256345-Drug Therapy, Combination, pubmed-meshheading:11256345-Duodenal Ulcer, pubmed-meshheading:11256345-Follow-Up Studies, pubmed-meshheading:11256345-Helicobacter Infections, pubmed-meshheading:11256345-Helicobacter pylori, pubmed-meshheading:11256345-Hospitalization, pubmed-meshheading:11256345-Humans, pubmed-meshheading:11256345-Middle Aged, pubmed-meshheading:11256345-Omeprazole, pubmed-meshheading:11256345-Penicillins, pubmed-meshheading:11256345-Population Surveillance, pubmed-meshheading:11256345-Recurrence, pubmed-meshheading:11256345-Singapore, pubmed-meshheading:11256345-Time Factors, pubmed-meshheading:11256345-Urban Health
pubmed:year
2000
pubmed:articleTitle
Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
pubmed:affiliation
Division of Gastroenterology, Department of Medicine, Changi General Hospital, 2 Simei St 3, Singapore 529889. ckhor@bigfoot.com
pubmed:publicationType
Journal Article